Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Abbott Laboratories (ABT) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2024-03-31

Income Statement Financials
Revenue	$9.96B
Net Income	$1.23B
Cost of Goods Sold	$4.46B
Gross Profit	$5.50B
Operating Expenses	$8.58B
Operating Income	$1.39B
Non-Operating Income/Expense	$50.00M
Pre-Tax Income	$1.44B
Normalized Pre-Tax Income	$1.44B
Income after Taxes	$1.23B
Income from Continuous Operations	$1.23B
Consolidated Net Income/Loss	$1.23B
Normalized Income after Taxes	$1.23B
EBIT	$1.39B
EBITDA	$2.19B
Weighted-Average Shares Outstanding (Basic)	1.74B
Weighted-Average Shares Outstanding (Diluted)	1.75B
Earnings per Share (EPS) (Basic)	$0.70
Earnings per Share (EPS) (Diluted)	$0.70
Balance Sheet Financials
Current Assets	$22.38B
Property, Plant, and Equipment	$10.11B
Long-Term Assets	$50.09B
Total Assets	$72.47B
Current Liabilities	$14.02B
Long-Term Debt	$12.58B
Long-Term Liabilities	$19.40B
Total Liabilities	$33.42B
Common Equity	$39.04B
Tangible Shareholders Equity	$7.36B
Shareholders Equity	$39.04B
Common Shares Outstanding	1.74B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.02B
Cash Flow from Investing Activities	$-425.00M
Cash Flow from Financial Activities	$-1.18B
Beginning Cash	$6.90B
End Cash	$6.28B
Increase/Decrease in Cash	$-612.00M
Stock-Based Compensation	$304.00M
Common Stock Dividends Paid	$-957.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.60
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.24
Debt to Equity Ratio	0.37
Gross Margin	55.21%
Operating Margin	13.91%
EBIT Margin	13.91%
EBITDA Margin	--
Pre-Tax Profit Margin	14.41%
Profit Margin	12.29%
Free Cash Flow	$627.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	0.65
Receiveable Turnover	1.51
Days Sales in Receivables	59.66
Return on Equity	3.14%
Return on Tangible Equity	16.64%
Return on Assets	1.69%
Return on Investments	2.37%
Book Value Per Share	$22.44
Free Cash Flow per Share	$0.36
Operating Cash Flow per Share	$0.59

Data from Zacks Investment Research, Inc.